Kiniksa (KNSA) director receives RSUs and options in equity grants
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc director Barry D. Quart reported compensation-related equity activity. He exercised vested Restricted Share Units (RSUs) into 2,799 Class A Ordinary Shares, bringing his directly held Class A Ordinary Shares to 15,345.
Quart also received new equity awards on May 29, 2026. He was granted 2,026 RSUs, each representing one Class A Ordinary Share, which vest in full on the earlier of the first anniversary of the grant date or the company’s next annual shareholder meeting. In addition, he received options for 12,158 Class A Ordinary Shares at an exercise price of $48.38, vesting in twelve substantially equal monthly installments over roughly one year.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option | 12,158 | $0.00 | -- |
| Grant/Award | Restricted Share Units | 2,026 | $0.00 | -- |
| Exercise | Restricted Share Units | 2,799 | $0.00 | -- |
| Exercise | Class A Ordinary Share | 2,799 | $0.00 | -- |
Footnotes (1)
- Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026. The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026. The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs.
Key Figures
Key Terms
vests financial
exercise price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.